A medical technology company has developed a novel, point-of-care electroencephalography (EEG) platform that enables rapid diagnosis and continuous monitoring of patients with serious neurological conditions, utilizing portable hardware and AI-powered algorithms. The system is FDA cleared for indicating suspected seizure activity and is designed for use in intensive care units and emergency rooms.